Genomma Lab: third-quarter net sales up 1.3% and net profit up 18.6%
Genomma Lab Internacional reported that its net sales for the third quarter of 2026 rose 1.3%, with an EBITDA margin of 21.0% and net profit growth of 18.6%. Sales in Latin America increased 12.2%, while Mexico returned to positive sell-out. The information comes from the company's original press release, distributed by PR Newswire.



-U11414532657WvU-1200x630%40diario_abc.jpg&w=1200&q=75)











